Salvage Therapy With High/Low Methotrexate for Loss of Response to Infliximab Dose Escalation

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The goal of the present study is to evaluate if addition of methotrexate can restore remission after loss of response to infliximab after dose escalation. another goal is to evaluate if low dose methotrexate can maintain remission achieved by regular dose methotrexate by 6 months.
Epistemonikos ID: b294b7771fed2963ac22569b4c9e2bb843f71e68
First added on: May 12, 2024